Dr. David Aaron Eichenbaum, MD

Dr. Eichenbaum practices at Retina Vitreous Associates of FL in Temple Terrace, Florida.

Dr. Eichenbaum's NPI, 1144251356, was assigned on July 5, 2006. Dr. Eichenbaum graduated from USF Health Morsani College of Medicine in 2001. Dr. Eichenbaum holds Florida license ME90466.

Dr. Eichenbaum's primary practice is Retina Vitreous Associates of FL, at 12903 N 56th St, Temple Terrace, FL 33617 in Hillsborough County. The practice phone is (813) 879-5795.

Dr. Eichenbaum's primary practice is Retina Vitreous Associates of FL in Temple Terrace, Florida. Dr. Eichenbaum is also affiliated with HCA Florida Northside Hospital. Dmand AI also links Dr. Eichenbaum to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eichenbaum practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Eichenbaum's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Eichenbaum is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Eichenbaum's licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Eichenbaum treats.

CMS data shows 93,487 Medicare services from Dr. Eichenbaum across 27 procedure codes in 2024, for 902 Medicare patients. Medicare paid $3,411,353 for them. Every service was in an office.

CMS counts 902 Medicare patients who saw Dr. Eichenbaum in 2026. The largest group is 75 to 84, with 351 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eichenbaum's median patient age at 74, with 54% women.

In 2026, Dr. Eichenbaum wrote 447 Medicare Part D claims for 176 patients. 54% of them were for generic drugs. CMS names the drug for 347 of them, across 10 drugs with 11 or more claims each, at $21,766 in total drug cost. In 2023, CMS named 350 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Eichenbaum for performance year 2026, reported as part of a group. Dr. Eichenbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 40 papers to Dr. Eichenbaum, published from 2018 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Intravitreal Injections, Angiogenesis Inhibitors and Visual Acuity. Dr. Eichenbaum has published most often in BMJ Open Ophthalmol. Dr. Eichenbaum's most frequent co-authors are Charles Clifton Wykoff, MD, PhD, Arshad Mohammad Khanani, MD and Veeral S. Sheth, MD.

Dmand AI links Dr. Eichenbaum to 5 clinical trials. Conditions studied include Geographic Atrophy, Macular Edema and Diabetic Retinopathy. ThromboGenics sponsors the most, 2. Open Payments lists research payments to Dr. Eichenbaum that name 1 trial.

CMS Open Payments shows 2,540 general payments to Dr. Eichenbaum from 53 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Genentech, Inc. paid the most, $745,799. It also lists 29 research payments totaling $56,601 from 2016 to 2025, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Eichenbaum, most recently CMS Stage 1 EHR in 2013.

Dr. Eichenbaum graduated from USF Health Morsani College of Medicine in 2001. Dr. Eichenbaum is a member of AAO.

Dr. Eichenbaum is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.